These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25100722)

  • 1. Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy.
    Vidaurre S; Fitzpatrick C; Burzio VA; Briones M; Villota C; Villegas J; Echenique J; Oliveira-Cruz L; Araya M; Borgna V; Socías T; Lopez C; Avila R; Burzio LO
    J Biol Chem; 2014 Sep; 289(39):27182-27198. PubMed ID: 25100722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes.
    Villota C; Campos A; Vidaurre S; Oliveira-Cruz L; Boccardo E; Burzio VA; Varas M; Villegas J; Villa LL; Valenzuela PD; Socías M; Roberts S; Burzio LO
    J Biol Chem; 2012 Jun; 287(25):21303-15. PubMed ID: 22539350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo knockdown of antisense non-coding mitochondrial RNAs by a lentiviral-encoded shRNA inhibits melanoma tumor growth and lung colonization.
    Varas-Godoy M; Lladser A; Farfan N; Villota C; Villegas J; Tapia JC; Burzio LO; Burzio VA; Valenzuela PDT
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):64-72. PubMed ID: 28707763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors.
    Fitzpatrick C; Bendek MF; Briones M; Farfán N; Silva VA; Nardocci G; Montecino M; Boland A; Deleuze JF; Villegas J; Villota C; Silva V; Lobos-Gonzalez L; Borgna V; Barrey E; Burzio LO; Burzio VA
    Cell Death Dis; 2019 May; 10(6):423. PubMed ID: 31142736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells.
    Landerer E; Villegas J; Burzio VA; Oliveira L; Villota C; Lopez C; Restovic F; Martinez R; Castillo O; Burzio LO
    Cell Oncol (Dordr); 2011 Aug; 34(4):297-305. PubMed ID: 21347712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors.
    Lobos-González L; Silva V; Araya M; Restovic F; Echenique J; Oliveira-Cruz L; Fitzpatrick C; Briones M; Villegas J; Villota C; Vidaurre S; Borgna V; Socias M; Valenzuela S; Lopez C; Socias T; Varas M; Díaz J; Burzio LO; Burzio VA
    Oncotarget; 2016 Sep; 7(36):58331-58350. PubMed ID: 27507060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense noncoding mitochondrial RNA-2 gives rise to miR-4485-3p by Dicer processing in vitro.
    Farfán N; Sanhueza N; Briones M; Burzio LO; Burzio VA
    Biol Res; 2021 Oct; 54(1):33. PubMed ID: 34666824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-18 E2 protein downregulates antisense noncoding mitochondrial RNA-2, delaying replicative senescence of human keratinocytes.
    Villota C; Varas-Godoy M; Jeldes E; Campos A; Villegas J; Borgna V; Burzio LO; Burzio VA
    Aging (Albany NY); 2018 Dec; 11(1):33-47. PubMed ID: 30595560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial ASncmtRNA-1 and ASncmtRNA-2 as potent targets to inhibit tumor growth and metastasis in the RenCa murine renal adenocarcinoma model.
    Borgna V; Villegas J; Burzio VA; Belmar S; Araya M; Jeldes E; Lobos-González L; Silva V; Villota C; Oliveira-Cruz L; Lopez C; Socias T; Castillo O; Burzio LO
    Oncotarget; 2017 Jul; 8(27):43692-43708. PubMed ID: 28620146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer.
    Rivas A; Burzio V; Landerer E; Borgna V; Gatica S; Ávila R; López C; Villota C; de la Fuente R; Echenique J; Burzio LO; Villegas J
    BMC Urol; 2012 Dec; 12():37. PubMed ID: 23249382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells.
    Burzio VA; Villota C; Villegas J; Landerer E; Boccardo E; Villa LL; Martínez R; Lopez C; Gaete F; Toro V; Rodriguez X; Burzio LO
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9430-4. PubMed ID: 19470459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-203 inhibits proliferation of HCC cells by targeting survivin.
    Wei W; Wanjun L; Hui S; Dongyue C; Xinjun Y; Jisheng Z
    Cell Biochem Funct; 2013 Jan; 31(1):82-5. PubMed ID: 22886454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antisense microRNA targeting survivin on rectal cancer HRC-9698 cells and its mechanism.
    Dai J; Wu W; Zhou J; Gao K; Hu G; Lin C; Zhang Y; Li X
    Int J Clin Exp Pathol; 2015; 8(6):6057-63. PubMed ID: 26261483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
    Yang L; Cao Z; Yan H; Wood WC
    Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
    Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
    Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse Modulation of Aurora Kinase A and Topoisomerase IIα in Normal and Tumor Breast Cells upon Knockdown of Mitochondrial ASncmtRNA.
    Bendek MF; Fitzpatrick C; Jeldes E; Boland A; Deleuze JF; Farfán N; Villegas J; Nardocci G; Montecino M; Burzio LO; Burzio VA
    Noncoding RNA; 2023 Oct; 9(5):. PubMed ID: 37888205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noscapine induced apoptosis via downregulation of survivin in human neuroblastoma cells having wild type or null p53.
    Li S; He J; Li S; Cao G; Tang S; Tong Q; Joshi HC
    PLoS One; 2012; 7(7):e40076. PubMed ID: 22848370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting.
    Ambrosini G; Adida C; Sirugo G; Altieri DC
    J Biol Chem; 1998 May; 273(18):11177-82. PubMed ID: 9556606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin].
    Dai DJ; Lu CD; Guo JM; Zhang J
    Ai Zheng; 2005 Aug; 24(8):951-7. PubMed ID: 16086872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.